Preterm neonates display altered plasmacytoid dendritic cell function and morphology

Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here, the authors present three cases of BPDCN diagnosed in the past two years and address different available diagnostic modalities such as morpho...

Constitutive Plasmacytoid Dendritic Cell

Blastic Plasmacytoid Dendritic Cell Neoplasm

Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It manifests as cutaneous and bone marrow involvement and leukemic spread. It represents 0.7% of primary cutaneous lymphomas. Recently, it was established as a distinct entity. We present a rare case of BPDCN with good response to chemotherapy and review the clinicopathologic...

Blastic plasmacytoid dendritic cell neoplasms

1Department of Hematology, Medical University of Łódź Head of Department: prof. Tadeusz Robak, MD, PhD 2Department of Experimental Hematology, Medical University of Łódź Head of Department: prof. Piotr Smolewski, MD, PhD 3Department of Pathology, Medical University of Łódź Head of Department: prof. Radzisław Kordek, MD, PhD 4Department of Cytogenetic, The Maria Skłodowska-Curie Memorial Cancer ...

Blastic plasmacytoid dendritic cell neoplasm.

A 81-year-old man had multiple skin lesions (brown-red plaques on the face, abdomen, and back) and asthenia. There was no hepatosplenomegaly or adenopathy. Despite normal blood count values, the peripheral smear contained blasts (7%). Bone marrow examination showed 50% of blasts and mild erythroid dysplasia. The abnormal cells were medium-sized with blastic round (panels A-B) or convoluted (pan...